Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs

Translational Research

Volumn 159, Issue 5, 2012, Pages 397-406

  Neuman, Manuela G ^a   Cohen, Lawrence ^a,b   Nanau, Radu M ^a   Hwang, Paul A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CASPASE 3; CASPASE 8; FAS ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LAMOTRIGINE; LEUKOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENYTOIN; RANTES; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ANTICONVULSANT THERAPY; APOPTOSIS; ARTICLE; CHINESE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRESS SYNDROME; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SERUM; STEVENS JOHNSON SYNDROME; TOXIC HEPATITIS; TOXICITY TESTING;

EID: 84859233592     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.01.004     Document Type: Article

References (82)

1. J.A. Ferrendelli, and G.C. Mathews Neuropharmacology of antiepileptic medications: mechanisms of action E. Wyllie, The treatment of epilepsy: principles and practice 1993 Lea and Febiger Philadelphia 735 737
2. N. Hockings, A. Pall, J. Moody, A.V. Davidson, and D.L. Davidson The effects of age on carbamazepine pharmacokinetics and adverse effects Br J Clin Pharmacol 22 1986 725 728
3. M. Bajpai, L.K. Roskos, D.D. Shen, and R.H. Levy Roles of cytochrome P450 2C9 and cytochrome P4502C19 in the streoselective metabolism of phenytoin to its major metabolite Drug Metab Dispos 24 1996 1401 1403
4. L. Cuttle, A.J. Munns, and N.A. Hogg Phenytoin metabolism by human cytochrome P450: Involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation Drug Metab Dispos 28 2000 945 950
5. K. Lertratanangkoon, and M.G. Horning Metabolism of carbamazepine Drug Metab Dispos 10 1982 1 10
6. W. Lu, and J.P. Uetrecht Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin Drug Metab Dispos 36 2008 1624 1636
7. E.M. Hawes N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group Drug Metab Dispos 26 1998 830 837
8. R. Schlienger, and N.H. Shear Antiepileptic drug hypersensitivity syndrome Epilepsia 39 1998 S3 S7
9. H.J. Zimmerman Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver 2nd ed. 1999 Lippincott Williams and Wilkins Philadelphia
10. E. Björnsson Hepatotoxicity associated with antiepileptic drugs Acta Neurol Scand 118 2008 281 290
11. J.R. Sullivan, and N.H. Shear The drug hypersensitvity syndrome: what is the pathogenesis? Arch Dematol 137 2001 357 364
12. K. Overstreet, C. Costanza, and C. Behling Fatal progressive hepatic necrosis associated with lamotrigine treatment Dig Dis Sci 47 2002 1921 1925
13. I. Valencia, G. Piñol-Ripoll, and D.S. Khurana Efficacy and safety of lamotrigine monotherapy in children and adolescent with epilepsy Eur J Paediatr Neurol 13 2009 141 145
14. B. Rzany, O. Hering, and M. Mockenhaupt Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis Br J Dermatol 135 1996 6 11
15. B. Rzany, M. Mockenhaupt, and S. Baur Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): Structure and results of a population-based registry J Clin Epidemiol 49 1996 769 773
16. N. Krivoy, M. Taeri, and M.G. Neuman Antiepileptic drug-induced hypersensitivity syndrome reactions Curr Drug Saf 1 2006 289 299
17. M. Mockenhaupt, C. Viboud, and A. Dunant Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study J Invest Dermatol 128 2008 35 44
18. H.J. Zimmerman The spectrum of hepatotoxicity Prospect Biol Med 12 1968 135 161
19. M.G. Neuman, R.G. Cameron, N.H. Shear, and G. Feuer Drug-induced apoptosis of skin cells and liver R.G. Cameron, G. Fauer, Handbook of experimental pharmacology: apoptosis and its modulation by drugs 1999 Springer Verlag Publishers Heidelberg 344 355
20. C. Bénichou Criteria of drug-induced liver disorders. Report of an international consensus meeting J Hepatol 11 1990 272 276
21. L.N. Bell, and N. Chalasani Epidemiology of idiosyncratic drug-induced liver injury Semin Liver Dis 29 2009 337 347
22. A.M. Stevens, and F.C. Johnson A new eruptive fever associated with stomatitis and ophthalmia. Report of two cases in children Am J Dis Child 4 1922 526 533
23. A. Lyell Toxic epidermal necrolysis: an eruption resembling scalding of the skin Br J Dermatol 68 1956 355 361
24. Y. Caraco, E. Zylber-Katz, E.M. Berry, and M. Levy Significant weight reduction in obese subjects enhances carbamazepine elimination Clin Pharmacol Ther 51 1992 501 506
25. M.G. Neuman, N.H. Shear, I.M. Malkiewicz, M. Kessas, A.W. Lee, and L. Cohen Predicting possible zonisamide hypersensitivity syndrome Exp Dermatol 17 2008 1045 1051
26. H.L. Chan, R.S. Stern, and K.A. Arndt The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population- based study with particular reference to reactions caused by drugs among outpatients Arch Dermatol 126 1990 43 47
27. L. Naldi, F. Locati, L. Marchesi, and T. Cainelli Incidence of toxic epidermal necrolysis in Italy Arch Dermatol 126 1990 1103 1104
28. J.C. Roujeau, J.C. Guillaume, J.P. Fabre, D. Penso, M.L. Flechet, and J.P. Girre Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985 Arch Dermatol 126 1990 37 42
29. H. Assier, S. Bastuji-Garin, J. Revuz, and J.C. Roujeau Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes Arch Dermatol 131 1995 539 543
30. H.L. Chan Toxic epidermal necrolysis in Singapore, 1989 through 1993: Incidence and antecedent drug exposure Arch Dermatol 131 1995 1212 1213
31. J.J. Kelemen III, W.G. Cioffi, W.F. McManus, A.D. Mason Jr., and B.A. Pruitt Jr. Burn center care for patients with toxic epidermal necrolysis J Am Coll Surg 180 1995 273 278
32. M.D. Kamaliah, D. Zainal, N. Mokhtar, and N. Nazmi Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Northeastern Malaysia Intern J Dermatol 37 1998 520 523
33. C.W. Kim, G.S. Choi, C.H. Yun, and D.I. Kim Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome J Korean Med Sci 21 2006 768 772
34. L.F. Li, and C. Ma Epidemiological study of severe cutaneous adverse drug reactions in a city district of China Clin Exp Dermatol 31 2006 642 647
35. P. Tennis, and R.S. Stern Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study Neurology 49 1997 542 546
36. J.P. Allam, T. Paus, C. Reichel, and T. Bieber Novak. DRESS syndrome associated with carbamazepine and phenytoin Eur J Dermatol 14 2004 339 342
37. A.K.M. Khoo, and C.L. Foo Toxic epidermal necrolysis in a burns centre: a 6-year review Burns 22 1996 275 278
38. I. Garcia-Doval, L. LeCleach, H. Bocquet, X.L. Otero, and J.C. Roujeau Toxic epidermal necrolysis and Stevens-Johnson syndrome Arch Dermatol 136 2000 323 327
39. N.R. Maldonado, J.S. Tello, E.R. Garcia-Baquero, and A.H. Castano Anticonvulsant hypersensitivity syndrome with fatal outcome Eur J Dermatol 12 2002 503 505
40. L.J. Hirsch, H. Arif, and E.A. Nahm Cross-sensitivity of skin rashes with antiepileptic drug use Neurology 71 2008 1527 1534
41. S.R. Knowles, and N.H. Shear Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum Dermatol Ther 22 2009 441 451
42. A.D. East-Innis, and D.S. Thompson Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica West Indian Med J 58 2009 227 230
43. H.Y. Lee, L.K. Tay, T. Thirumoorthy, and S.M. Pang Cutaneous adverse drug reactions in hospitalised patients Singapore Med J 51 2010 767 774
44. H.Y. Huang, X.Q. Luo, L.S. Chan, Z.H. Cao, X.F. Sun, and J.H. Xu Cutaneous adverse drug reactions in a hospital-based Chinese population Clin Exp Dermatol 36 2011 135 141
45. Y.C. Chen, H.C. Chiu, and C.Y. Chu Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases Arch Dermatol 146 2010 1373 1379
46. S.J. Um, S.K. Lee, and Y.H. Kim Clinical features of drug-induced hypersensitivity syndrome in 38 patients J Investig Allergol Clin Immunol 20 2010 556 562
47. H. Devarbhavi, D. Karanth, K. Prasanna, C. Adarsh, and M. Patil Drug-Induced liver injury with hypersensitivity features has a better outcome: a single center experience of 39 children and adolescents Hepatology 54 2011 1344 1350
48. W.Y. Ding, C.K. Lee, and S.E. Choon Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia Int J Dermatol 49 2010 834 841
49. W.H. Chung, S.I. Hung, and H.S. Hong A marker for Stevens-Johnson syndrome Nature 482 2004 486
50. C. Locharernkul, V. Shotelersuk, and N. Hirankarn HLA-B 1502 screening: time to clinical practice Epilepsia 51 2010 936 938
51. S. Hakimian, and J.W. Miller The genetics of antiepileptic drug-induced skin reactions Clin Pharmacol Ther 89 2011 908 910
52. N.H. Shear, and S.P. Spielberg Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk J Clin Invest 82 1988 1826 1832
53. M.G. Neuman, I.M. Malkiewicz, and N.H. Shear A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes Clin Biochem 33 2000 517 524
54. M.G. Neuman, I.M. Malkieiwcz, and E.J. Phillips Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus infected individuals Ther Drug Monit 24 2002 728 736
55. M.G. Neuman, and M. Nicar Ibuprophen-induced toxic epidermal necrolysis Transl Res 149 2007 254 259
56. W.J. Pichler, N. Yawalkar, and M. Britschgi Cellular and molecular pathophysiology of cutaneous drug reactions Am J Clin Dermatol 3 2002 229 238
57. M.G. Neuman, N. Shear, and I. Malkiewicz Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides Transl Res 149 2007 243 253
58. G.R. Kazeem, C. Cox, J. Aponte, J. Messenheimer, C. Brazell, and A.C. Nelsen High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients Pharmacogenet Genomics 19 2009 661 665
59. C. Hyson, and M. Sadler Cross sensitivity of skin rashes with antiepileptic drugs Can J Neurol Sci 24 1997 245 249
60. D.M. Moss, M. Rudis, and S.O. Henderson Cross-sensitivity and the anticonvulsant hypersensitivity syndrome J Emerg Med 17 1999 503 506
61. K.L. Kwong, S.Y. Lam, Y.S. Lui, S.N. Wong, and K.T. So Cross-sensitivity in a child with anticonvulsant hypersensitivity syndrome J Paediatr Child Health 42 2006 474 476
62. V. Mendiratta, and P. Bhushan Phenytoin-induced DRESS with cross-reactivity to carbamazepine in a 10-year-old Indian child Clin Exp Dermatol 31 2006 720 721
63. A. Romano, R. Pettinato, and M. Andriolo Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies Curr Pharm Des 12 2006 3373 3381
64. C.S. Seitz, P. Pfeuffer, P. Raith, E.B. Brocker, and A. Trautmann Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents Ann Alergy Asthma Immunol 97 2006 698 702
65. T. Fujita, T. Matsuoka, T. Honda, K. Kabashima, T. Hirata, and S. Narumiya A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation J Invest Dermatol 131 2011 1660 1667
66. C. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095 2147
67. R. Abe, T. Shimizu, A. Shibaki, H. Nakamura, H. Watanabe, and H. Shimizu Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand Am J Pathol 162 2003 1515 1520
68. S.I. Hung, W.H. Chung, and Z.S. Liu Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese Pharmacogenomics 11 2010 349 356
69. S.I. Hung, W.H. Chung, and S.H. Jee Genetic susceptibility to Carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet Genomics 16 2006 297 306
70. C.B. Man, P. Kwan, and L. Baum Association between HLA-B1502 Allele and Antiepileptic drug-induced cutaneous reactions in Han Chinese Epilepsia 48 2007 1015 1018
71. M.A. Odueyungbo, M.P. Sheehan, and A.N. Haggstrom HLA-B1502 allele associated with carbamazepine-induced epidermal necrolysis Arch Dermatol 146 2010 1437 1438
72. C. Locharernkul, J. Loplumlert, and C. Limotai Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B1502 allele in Thai population Epilepsia 49 2008 2087 2091
73. W. Tassaneeyakul, S. Tiamkao, and T. Jantararoungtong Association between HLA-B1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population Epilepsia 51 2010 926 930
74. C.C. Chang, C.L. Too, S. Murad, and S.H. Hussein Association of HLA-B1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population Int J Dermatol 50 2011 221 224
75. T.Y. Mehta, L.M. Prajapati, and B. Mittal Association of HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians Indian J Dermatol Venereol Leprol 75 2009 579 582
76. C. Lonjou, L. Thomas, N. Borot, N. Ledger, C. de Toma RegiSCAR Group A marker for Steven-Johnson syndrome-ethnicity matters Pharmacogenomics J 6 2006 265 268
77. M. McCormack, A. Alfirevic, and S. Bourgeois HLA-A3101 and carbamazepine-induced hypersensitivity reactions in Europeans N Engl J Med 364 2011 1134 1143
78. N. Kaniwa, Y. Saito, and M. Aihara HLA-B1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients Epilepsia 51 2010 2461 2465
79. T. Ozeki, T. Mushiroda, and A. Yowang Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population Hum Mol Genet 20 2011 1034 1041
80. X.T. Wu, F.Y. Hu, and D.M. An Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B1502 allele among patients in central China Epilepsy Behav 19 2010 405 408
81. F.Y. Hu, X.T. Wu, D.M. An, B. Yan, H. Stefan, and D. Zhou Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B1502 allele in Chinese Han population Seizure 20 2011 160 162
82. W.H. Chung, S.I. Hung, and Y.T. Chen Human leukocyte antigens and drug hypersensitivity Curr Opin Allergy Clin Immunol 7 2007 317 323